Onconova Therapeutics Inc (ONTX) is scheduled to report 3rd quarter earnings on 11/14/2023, after the market closes.
Regarding Q3 estimates, Wall Street analysts expect Onconova Therapeutics Inc to post earnings of -$0.29 per share. Revenue expectations are pegged at $69 thousand. Last quarter, Onconova Therapeutics Inc beat earnings estimates, reporting EPS of -$0.20 on estimates of -$0.31. The stock fell by -5.88% the day after the last earnings release.
Year-to-date, ONTX stock has fallen by -9.86%.
About Onconova Therapeutics Inc
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
Stay up-to-date on earnings this week, with TipRanks’ Earnings Calendar.
